Field of Application
Biophysics
Title
Chief Physician
weifulv@ustc.edu.cn
Main Administrative or Academic Positions
1. Director of the Imaging Department, First Affiliated Hospital, University of Science and Technology of China
2. Chair of the Medical Imaging Committee, Anhui Medical Association
3. Vice Chair of the Tumor Specialist Committee, Interventional Branch, Chinese Medical Doctor Association
Education, Work, and Overseas Experience
1. 2012.09–2015.06: Ph.D. in Imaging and Nuclear Medicine, Shandong University
2. 1990.08–1993.07: Master’s in Imaging and Nuclear Medicine, Third Military Medical University
3. Since 1999.10: Imaging Department, First Affiliated Hospital, University of Science and Technology of China
Main Research Areas and Features
Focus on minimally invasive interventional treatment of malignant tumors (including transcatheter chemoembolization, radiofrequency, microwave, and iodine-125 seed implantation) and related molecular mechanisms, as well as comparative imaging studies of tumors.
Current research directions in biology include
1. Mechanism of drug-loaded microspheres in transcatheter chemoembolization of malignant tumors
2. Changes in gut microbiota after interventional treatment of liver cancer and their role and mechanisms in disease progression
Representative Achievements
1. Minimally Invasive Interventional Treatment of Liver Cancer:
- Key discipline in Anhui Province
- Completed approximately 15,000 interventional surgeries in the past decade
- Published 8 SCI papers
- Received 2 Anhui Science and Technology Progress Awards
- Leading national health commission research project and Anhui Science and Technology Project
- Over 1 million RMB in research funding
2. Comprehensive Imaging Evaluation and Molecular Imaging Research on Malignant Tumor Interventional Treatment:
- Published over 30 papers
Recent Publications (Last 5 Years)
1. Lv WF, et al. Liver Abscess Formation Following Transarterial Chemoembolization. Medicine, 2016; 95(17):e3503
2. Lv WF, et al. CT Perfusion Imaging Predicts Survival and Response to Chemo-Lipiodol Infusion for Liver Metastases. Korean J Radiol, 2015; 16(4):810-820.
3. Lv WF, et al. Side Effects of CT-Guided Iodine-125 Seed Implantation for Advanced Pancreatic Cancer. Medicine (Baltimore). 2017; 96(52):e9535.
4. Zhu HD, et al. Lancet Oncol. 2014; 15(6):612-619.
Current Research Projects (Main Leader Only)
1. Development of 125I Seed Irradiation Vascular Stent for Liver Cancer with Portal Vein Tumor Thrombus, Anhui Science and Technology Project, 2017
- Total Funding: 600,000 RMB (300,000 from government, 300,000 from hospital)
- Duration: 2017/01/01-2019/12/31
2. Study on Gut Microbiota Changes after TACE for Liver Cancer and Their Impact on Efficacy, Anhui Provincial Natural Science Foundation, 2018
- Total Funding: 160,000 RMB
- Duration: 2018/01/01-2020/12/31